Silexion Therapeutics Corp. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Is Silexion Therapeutics Corp. technically bullish or bearish?

20-Sep-2025

As of October 1, 2023, Silexion Therapeutics Corp. shows a bearish technical stance despite some bullish signals from MACD and RSI, with a year-to-date return of -88.03% compared to the S&P 500's 12.22%.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 5 Million ()

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.13

Return on Equity

-999,999.00%

Price to Book

5.19

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-3 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-57.76%

6 Months

-78.15%

1 Year

-93.51%

2 Years

-99.79%

3 Years

-69.86%

4 Years

-69.03%

5 Years

0.0%

Silexion Therapeutics Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Silexion Therapeutics Corp. technically bullish or bearish?

As of 1 October 2023, the technical stance for Silexion Therapeutics Corp. is bearish, with overall weakness indicated by multiple metrics. The MACD shows a mildly bullish signal on both weekly and monthly time frames, while the RSI is bullish in the same periods. However, the Bollinger Bands, KST, and Dow Theory all indicate bearish trends on both weekly and monthly levels. The daily moving averages are also bearish. The stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -88.03% versus the S&P 500's 12.22%, highlighting a stark contrast in performance....

Silexion Therapeutics Corp. Stock Plummets to New 52-Week Low of $3.37

Silexion Therapeutics Corp. has reached a new 52-week low, reflecting significant volatility in the pharmaceuticals and biotechnology sector. With a market capitalization of USD 5 million, the company faces operational challenges, evidenced by a low return on equity and a lack of dividends, amid a contrasting performance compared to the S&P 500.

Silexion Therapeutics Corp. Stock Plummets to New 52-Week Low of $3.44

Silexion Therapeutics Corp. has reached a new 52-week low, reflecting a significant decline in its stock performance compared to the S&P 500. With a market capitalization of USD 5 million, the company faces challenges indicated by its high price-to-book ratio and negative return on equity, raising questions about its future strategies.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-328.50%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

EV to EBITDA

EV to Capital Employed

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

Bullish

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -47.06% vs 0.00% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.30",
          "val2": "-1.60",
          "chgp": "-43.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.20",
          "val2": "-0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.50",
          "val2": "-1.70",
          "chgp": "-47.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -223.53% vs -950.00% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-12.50",
          "val2": "-4.60",
          "chgp": "-171.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.10",
          "val2": "-0.10",
          "chgp": "1,200.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-16.50",
          "val2": "-5.10",
          "chgp": "-223.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-2.30

-1.60

-43.75%

Interest

0.00

Exceptional Items

-0.20

-0.10

-100.00%

Consolidate Net Profit

-2.50

-1.70

-47.06%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -47.06% vs 0.00% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-12.50

-4.60

-171.74%

Interest

0.10

0.00

Exceptional Items

1.10

-0.10

1,200.00%

Consolidate Net Profit

-16.50

-5.10

-223.53%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -223.53% vs -950.00% in Dec 2023

All Annual Results

Company CV

About

Company Coordinates

Company Details

Tel:

Registrar Details

Silexion Therapeutics Corp.

1Day

52 Week

CASH

FII

DII

Promoter

Is Silexion Therapeutics Corp. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Silexion Therapeutics Corp. technically bullish or bearish?

Silexion Therapeutics Corp. Stock Plummets to New 52-Week Low of $3.37

Silexion Therapeutics Corp. Stock Plummets to New 52-Week Low of $3.44

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Annual Results Snapshot (Consolidated) - Dec'24

About

Company Coordinates